鶹ý

Imcivree Label Expanded; Weight Loss With Weekly Injection; Kidney Donation Chain

— News and commentary from the endocrinology world

MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

The FDA to include children as young as 2 years with syndromic or monogenic obesity due to Bardet-Biedl syndrome or genetically confirmed pro-opiomelanocortin, said maker Rhythm Pharmaceuticals.

Among patients with type 2 diabetic nephropathy receiving bremelanotide in the small phase IIb BREAKOUT study, 71% in urine protein to creatinine ratio at 6 months, Palatin Technologies announced.

In a draft recommendation, the U.S. Preventive Services Task Force said that older adults should not for the primary prevention of falls and fractures.

Even after surgery, patients with Cushing's syndrome have an , "indicating a possible target for additional probiotic interventions to accelerate convergence to a healthy microbiome," authors of a longitudinal analysis concluded. (Journal of Clinical Endocrinology & Metabolism)

A consisting of a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg (Wegovy) led to greater weight loss by week 68 compared with either drug alone or placebo in the phase III REDEFINE 1 trial, Novo Nordisk said.

In a cross-sectional survey of midlife female veterans, sexual-minority women self-reported on sexual function compared with their heterosexual peers. (Menopause)

The Ohio State University Wexner Medical Center Comprehensive Transplant Center set a with 20 surgeries over a 2-day period. (Columbus Dispatch)

People are -- and getting diagnosed with other conditions along the way. (Reuters via Quartz)

Palopegteriparatide (Yorvipath), the only FDA-approved treatment for hypoparathyroidism in adults, ., said Ascendis Pharma.

Police raided the home of a woman in Medina, Tennessee, finding . (NBC News)

For patients wanting to pause their GLP-1 drugs this holiday season, they should know. (CNN)

In a JAMA viewpoint, WHO officials noted that the global health systems community "must be mindful that " to treat obesity, even with the availability of highly effective GLP-1 receptor agonists.

After gender-affirming surgery disappeared in the U.S. for decades, trans patients and advocates are to such care. (STAT)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.